Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (61-70 of 336) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Publication of tumor marker research results: the necessity for complete and transparent reportingLisa M McShane, Daniel F Hayes
Breast Cancer Research : BCR|September 7, 2006
Recent translational research: circulating tumor cells in breast cancer patientsVolkmar Müller, Daniel F Hayes, Klaus Pantel
Journal of the National Cancer Institute|September 21, 2006
Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?Catherine H Van Poznak, Daniel F Hayes
The New England Journal of Medicine|March 1, 2018
Breast-Cancer Recurrence after Stopping Endocrine TherapyHongchao Pan, Richard Gray, Daniel F Hayes, et al.
Breast (Edinburgh, Scotland)|August 21, 2007
Angiogenesis as targeted breast cancer therapyDaniel F Hayes, Kathy Miller, George Sledge
Breast Cancer Research and Treatment|June 15, 2006
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARKDaniel F Hayes, Stephen Ethier, Marc E Lippman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Why Hasn't Genomic Testing Changed the Landscape in Clinical Oncology?Daniel F Hayes, Muin J Khoury, David Ransohoff
Journal of the National Cancer Institute|October 10, 2009
Use of archived specimens in evaluation of prognostic and predictive biomarkersRichard M Simon, Soonmyung Paik, Daniel F Hayes
British Journal of Cancer|December 8, 2022
REMARK guidelines for tumour biomarker study reporting: a remarkable historyDaniel F Hayes, Willi Sauerbrei, Lisa M McShane
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Surveillance and monitoring in breast cancer survivors: maximizing benefit and minimizing harmMaxine Jochelson, Daniel F Hayes, Patricia A Ganz
Pageof 34

Showing results (61-70 of 336) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Publication of tumor marker research results: the necessity for complete and transparent reportingLisa M McShane, Daniel F Hayes
Breast Cancer Research : BCR|September 7, 2006
Recent translational research: circulating tumor cells in breast cancer patientsVolkmar Müller, Daniel F Hayes, Klaus Pantel
Journal of the National Cancer Institute|September 21, 2006
Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?Catherine H Van Poznak, Daniel F Hayes
The New England Journal of Medicine|March 1, 2018
Breast-Cancer Recurrence after Stopping Endocrine TherapyHongchao Pan, Richard Gray, Daniel F Hayes, et al.
Breast (Edinburgh, Scotland)|August 21, 2007
Angiogenesis as targeted breast cancer therapyDaniel F Hayes, Kathy Miller, George Sledge
Breast Cancer Research and Treatment|June 15, 2006
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARKDaniel F Hayes, Stephen Ethier, Marc E Lippman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Why Hasn't Genomic Testing Changed the Landscape in Clinical Oncology?Daniel F Hayes, Muin J Khoury, David Ransohoff
Journal of the National Cancer Institute|October 10, 2009
Use of archived specimens in evaluation of prognostic and predictive biomarkersRichard M Simon, Soonmyung Paik, Daniel F Hayes
British Journal of Cancer|December 8, 2022
REMARK guidelines for tumour biomarker study reporting: a remarkable historyDaniel F Hayes, Willi Sauerbrei, Lisa M McShane
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Surveillance and monitoring in breast cancer survivors: maximizing benefit and minimizing harmMaxine Jochelson, Daniel F Hayes, Patricia A Ganz
Pageof 34